Reconstitution activity of hypoxic cultured human cord blood CD34-positive cells in NOG mice
Haruko Shima(Keio University), Toshio Suda(Chinese Academy of Sciences), Kentaro Hosokawa(Kyushu University), Keiyo Takubo(Keio University), Fumio Arai(Kyushu University), Takao Takahashi(Maruyama Memorial General Hospital), Yumiko Gomei(Keio University), Hiroko Iwasaki(Keio University), Hiroki Yoshihara(St. Jude Children's Research Hospital)
Cited by 46
Related Papers
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis<i>in Vitro</i><sup>1</sup>
|Endocrinology|1998|1.2k
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
|The Journal of Experimental Medicine|2005|899
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis
|Cell Metabolism|2006|771
Commitment and Differentiation of Osteoclast Precursor Cells by the Sequential Expression of C-Fms and Receptor Activator of Nuclear Factor κb (Rank) Receptors
|The Journal of Experimental Medicine|1999|694